DK1419177T3 - Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin - Google Patents

Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin

Info

Publication number
DK1419177T3
DK1419177T3 DK02754557T DK02754557T DK1419177T3 DK 1419177 T3 DK1419177 T3 DK 1419177T3 DK 02754557 T DK02754557 T DK 02754557T DK 02754557 T DK02754557 T DK 02754557T DK 1419177 T3 DK1419177 T3 DK 1419177T3
Authority
DK
Denmark
Prior art keywords
globulin
medicine
scale production
purification process
product
Prior art date
Application number
DK02754557T
Other languages
Danish (da)
English (en)
Inventor
Inga Laursen
Gunnar Houen
Charlotte Svaerke Jorgensen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of DK1419177T3 publication Critical patent/DK1419177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DK02754557T 2001-08-14 2002-08-12 Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin DK1419177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14
PCT/DK2002/000531 WO2003016348A2 (fr) 2001-08-14 2002-08-12 Procede de purification permettant de produire une globuline gc a grande echelle, globuline gc produite, utilisation de ladite globuline gc et produit medical a base de globuline gc

Publications (1)

Publication Number Publication Date
DK1419177T3 true DK1419177T3 (da) 2008-08-25

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754557T DK1419177T3 (da) 2001-08-14 2002-08-12 Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin

Country Status (9)

Country Link
EP (1) EP1419177B1 (fr)
JP (1) JP2005508892A (fr)
AT (1) ATE393780T1 (fr)
AU (1) AU2002321012B2 (fr)
CA (1) CA2456843A1 (fr)
DE (1) DE60226327T2 (fr)
DK (1) DK1419177T3 (fr)
ES (1) ES2305272T3 (fr)
WO (1) WO2003016348A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5112060B2 (ja) * 2004-06-29 2013-01-09 リライアンス ライフ サイエンシーズ プライベイト リミテッド ウイルス安全性生物学的流体の調製のための方法
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
BR112012030530A2 (pt) * 2010-05-18 2022-12-20 Abbvie Inc Aparelho e processo para purificação de proteínas
WO2012029954A1 (fr) 2010-09-03 2012-03-08 国立大学法人徳島大学 Procédé de production d'une nouvelle gc globuline dégalactosylée
EP2682168A1 (fr) 2012-07-02 2014-01-08 Millipore Corporation Dispositif de tirage et métier à filer
EP3081221B1 (fr) * 2013-12-13 2021-08-25 Saisei Pharma Co., Ltd. Composition pharmaceutique comprenant un produit traité d'enzyme de colostrum bovin
CN106456813B (zh) * 2014-04-15 2020-06-30 勃林格殷格翰国际公司 在制造生物制品期间连续灭活病毒的方法、装置和系统
WO2016194914A1 (fr) * 2015-06-01 2016-12-08 再生ファーマ株式会社 Produit laitier traité aux enzymes, procédé de production de celui-ci, composition et produit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
WO1991015770A1 (fr) * 1990-04-11 1991-10-17 The General Hospital Corporation Emplois therapeutiques de composes de liaison d'actine
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Also Published As

Publication number Publication date
JP2005508892A (ja) 2005-04-07
AU2002321012B2 (en) 2008-07-24
CA2456843A1 (fr) 2003-02-27
ES2305272T3 (es) 2008-11-01
DE60226327T2 (de) 2009-07-09
DE60226327D1 (de) 2008-06-12
ATE393780T1 (de) 2008-05-15
WO2003016348A2 (fr) 2003-02-27
WO2003016348A3 (fr) 2004-03-04
EP1419177B1 (fr) 2008-04-30
EP1419177A2 (fr) 2004-05-19

Similar Documents

Publication Publication Date Title
DE602004030369D1 (de) Therapieverfahren
EP1728076A4 (fr) Systeme et procede destines a fournir des concentrations optimales pour des infusions de medicaments
DK1419177T3 (da) Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin
WO1995025171A3 (fr) Sequences d'adn pour metalloproteases matricielles, leur production et leur utilisation
CN101669960B (zh) 木通皂苷d及其组合物在制备防治老年痴呆药中的应用
Chen et al. Adjustable parameters and the effectiveness of adjunct robot-assisted gait training in individuals with chronic stroke
CN104224863A (zh) 金钱草总黄酮在制备降低高尿酸血症药物中的应用
Lee et al. The effect of family support, self-efficacy, and fatigue on the quality of life in hemodialysis patients
Sun et al. Rosuvastatin inhibits the smooth muscle cell proliferation by targeting TNFα mediated Rho kinase pathway
Kwan et al. Rehabilitation of proximal humerus fractures: An environmental scan of Canadian physiotherapy practice patterns
CN202776947U (zh) 一种带储液瓶的刮板装置
Zhang et al. Electroacupuncture promotes nerve regeneration and functional recovery in rats with spinal cord contusion through the coordinate interaction of CD4 and BDNF
CN108347886A (zh) 具降低疼痛功效的猴头萜、猴头菇菌丝体活性物质、其制备方法、及含其的医药组合物
CN103789291A (zh) 一种重组大肠杆菌发酵液中分离纯化重组人尿激酶原的制备工艺
CN102847137A (zh) 抑血管生成素的药物用途
CN103893322B (zh) 一种治疗老年痴呆症的中药有效部位及其制备方法与应用
Dai et al. Effect of Acupuncture on Serum SOD and MDA of Rats in Menopause
CN106279406A (zh) 猪皮中分离纯化的皮抑素g1的活性成分四连接素及其应用
RU2489172C1 (ru) Способ проведения лечебного дискретного плазмафереза с экстракарпоральной модификацией эритроцитов и лейкоцитов индукторами интерферона, антиоксидантами и протекторами клеток
Jabraeili et al. The Effects of Field massage on urine cortisol level in premature infants: clinical trial
CN105998313A (zh) 一种彻底治疗心脑血管疾病的中药配方
Park et al. Two Case Reports of Leukocytoclastic Vasculitis after ChAdOxl nCoV-19 Vaccine
Guida et al. ORCID ID 0000-0003-1027-7049. Genetic Polymorphism in Porphyria: Resolution of A Case of Tetraplegia by Administration of Hemin During a Porphyric Crisis and Subsequent Therapeutic Procedure with the use of Givosiran
Nahler et al. biologic equivalent
Nahler et al. biorepository